SWOG S1505: Phase II Study of Perioperative CT With mFOLFIRINOX vs Gemcitabine/nab-Paclitaxel in Resectable Pancreatic Ductal Adenocarcinoma

May 29-31, 2020; Online at meetings.asco.org/am
The S1505 trial failed to meet primary endpoint of 2-year OS rate ≥ 58% with perioperative mFOLFIRINOX or gemcitabine/nab-paclitaxel.
Format: Microsoft PowerPoint (.ppt)
File Size: 212 KB
Released: June 4, 2020

Acknowledgements

Provided by Clinical Care Options, LLC.

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Daiichi Sankyo, Inc.

Related Content

In this slideset from Clinical Care Options (CCO), experts discuss new data on gastrointestinal (GI) cancers from ASCO 2020

Axel Grothey Headshot Axel Grothey, MD Manish A. Shah, MD Released: August 7, 2020

From Clinical Care Options (CCO), Axel Grothey, MD, and Manish A. Shah, MD, discuss new data on gastrointestinal (GI) cancers from ASCO 2020

Axel Grothey Headshot Axel Grothey, MD Manish A. Shah, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: August 7, 2020 Expired: August 6, 2021

From Clinical Care Options (CCO), watch this video featuring expert nurse perspectives on new and emerging biomarkers critical to the care of patients with cancer

Elisabeth King, RN, FNP, AGN, AOCNP
Program Director
person default Diane Cope, PhD, ARNP-BC, AOCNP Sara Toth, RN, MSN, FNP-C, AOCNP, AGN-BC
Registered Nurses: 1.75 Nursing contact hours Released: July 21, 2020 Expired: July 20, 2021

A short slideset from Clinical Care Options covering key clinical updates and strategies for the current management of advanced Lung and GI cancers

person default Mary Jo Fidler, MD John L. Marshall, MD Released: July 13, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?